Combined oral contraceptive (1st-generation progestogen)
Ethinylestradiol with norethisterone
Brand names: Ovysmen, Loestrin, Brevinor
Adult dose
Dose: 1 tablet OD per pack regimen
Route: Oral
Frequency: OD
Clinical pearls
- FSRH-recommended low-VTE-risk progestogen alongside levonorgestrel for first-line CHC choice
- Useful in women preferring well-established formulations
Contraindications
- Standard CHC contraindications
Side effects
- Breakthrough bleeding
- VTE (low — comparable to levonorgestrel)
- Headache
- Mood change
- Acne (less anti-androgenic than newer)
Interactions
- Enzyme inducers
- Lamotrigine
Monitoring
- BP
- Migraine status
- BMI
Reference: BNF; FSRH CHC guideline; UKMEC; MHRA Drug Safety Update; https://bnf.nice.org.uk/drugs/ethinylestradiol-with-norethisterone/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Spinal Anaesthesia Hypotension Management · AAGBI; ASA
- Pre-Eclampsia / Eclampsia in ED · NICE NG133; RCOG Green-top 10A
- Suspected Ectopic Pregnancy · NICE NG126; RCOG Green-top 21
- Polycystic Ovary Syndrome (PCOS) · International PCOS Guideline 2023; NICE CKS
- Pre-eclampsia Management · NICE NG133 2019
- Ectopic Pregnancy · NICE CG154 / RCOG GTG 21